Select Page
The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines
EPHA #A2MDialogues
Register here

25 November 2020



Our fourth dialogue in a series of online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe. 

Following the publication of the EU’s Pharmaceutical Strategy by the European Commission, senior representatives of the German Presidency and upcoming Presidencies (Portugal & Slovenia) offer their perspective on what should be prioritised and debate the next steps in European pharmaceutical policy 

#A2M Dialogues


Senior representatives of Member States (tbc)

Moderated by

Yannis Natsis,

Policy Manager, Universal Access to Affordable Medicines

European Public Health Alliance

Register for EPHA’s other A2M Dialogues below

Unleashing meaningful innovation through regulatory reform

19 October 2020


The EU's IP strategy: Enabler or barrier?

27 October 2020


Pharma & COVID19: Winners, losers, prospects

19 November 2020


Follow on social media




Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines, EPHA